Skip to main content
. 2014 Oct 6;9(10):e108743. doi: 10.1371/journal.pone.0108743

Figure 3. RPL31 is overexpressed in BicR cells and clinical prostate cancer tissues.

Figure 3

(A) Expression levels of RPL31, HIST1H2BD, and ADAMTS1 mRNA evaluated by quantitative reverse-transcription PCR analysis (qRT-PCR) with gene-specific primers. Data are normalized to GAPDH and shown as mean ± s.d. (n = 3; **, P<0.01). (B) RPL31 mRNA is abundantly expressed in clinical prostate carcinoma tissues compared with normal prostate tissues (by > 2-fold), as retrieved from datasets by Tomlins et al. in the ONCOMINE database [30]. Normal: normal prostate tissue, PCa: prostate cancer, PIN: prostatic intraepithelial neoplasia. (C) RPL31 mRNA expression is elevated in clinical prostate cancer samples versus normal samples in a study of RNA-sequencing in The Cancer Genome Analysis [31], [32].